Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Aeterna Zentaris (AEZS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 35,839
  • Shares Outstanding, K 16,440
  • Annual Sales, $ 910 K
  • Annual Income, $ -24,960 K
  • 36-Month Beta 0.87
  • Price/Sales 39.70
  • Price/Cash Flow N/A
  • Price/Book N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.89 +15.34%
on 11/15/17
2.40 -9.17%
on 12/11/17
+0.13 (+6.34%)
since 11/10/17
3-Month
1.81 +20.44%
on 10/27/17
2.47 -11.74%
on 10/12/17
+0.18 (+9.00%)
since 09/12/17
52-Week
0.78 +179.49%
on 05/09/17
4.25 -48.71%
on 12/23/16
-1.67 (-43.38%)
since 12/12/16

Most Recent Stories

More News
Aeterna Zentaris Announces Departure of Interim Chief Financial Officer

Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) (the "Company") announced today the departure of the Company's Interim Chief Financial Officer, Jeffrey Whitnell, effective December 7, 2017. The Company...

AEZS.TO : 2.78 (-1.77%)
AEZS : 2.18 (-0.91%)
Biotech's Flying Under The Radar

Biotech investors spend a ton of time considering what the cure for cancer could be or the next invention that could eliminate a rare disease. It's difficult to keep track of the advancements and developments...

ESPR : 56.08 (-1.84%)
AEZS : 2.18 (-0.91%)
PPCB : 0.1800 (-9.46%)
GERN : 1.97 (-1.01%)
CPRX : 4.17 (-0.71%)
Today's Research Reports on Trending Tickers: Aeterna Zentaris and Intercept Pharmaceuticals

NEW YORK, NY / ACCESSWIRE / November 28, 2017 / U.S. markets were mixed Monday as retailers surged on strong holiday sales numbers, while chipmakers and oil stocks dragged. The Dow Jones Industrial Average...

AEZS : 2.18 (-0.91%)
ICPT : 60.64 (-1.14%)
Aeterna Zentaris Reports Third Quarter 2017 Financial and Operating Results

Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the "Company"), a specialty biopharmaceutical company engaged in developing and commercializing novel pharmaceutical therapies, today reported...

AEZS.TO : 2.78 (-1.77%)
AEZS : 2.18 (-0.91%)
Aeterna Zentaris to Announce Third Quarter 2017 Financial and Operating Results on November 8, 2017

Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the "Company") will announce its third quarter 2017 financial and operating results after market close on Wednesday, November 8, 2017. The...

AEZS.TO : 2.78 (-1.77%)
AEZS : 2.18 (-0.91%)
Biotech Stocks on Investors' Radar -- Synthetic Biologics, 22nd Century, Abeona Therapeutics, and Aeterna Zentaris

If you want a Stock Review on SYN, XXII, ABEO, or AEZS then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. On Monday, October 30, 2017, US markets saw...

AEZS : 2.18 (-0.91%)
ABEO : 15.45 (-0.64%)
XXII : 2.63 (-6.74%)
SYN : 0.51 (-4.67%)
Aeterna Zentaris Announces Appointment of Interim Chief Financial Officer

Aeterna Zentaris Inc. (NASDAQ & TSX: AEZS) a specialty biopharmaceutical company (the "Company") announced effective today, September 25, 2017, that Jeffrey Whitnell has been appointed to...

AEZS.TO : 2.78 (-1.77%)
AEZS : 2.18 (-0.91%)
BEAT : 28.30 (+1.98%)
AKRX : 32.20 (-1.35%)
Aeterna Zentaris Announces Departure of Vice President, Finance & Chief Accounting Officer

Aeterna Zentaris Inc. (NASDAQ: AEZS)(TSX: AEZS) (the "Company") announced today the departure of the Company's Vice President, Finance & Chief Accounting Officer, Genevieve Lemaire, effective...

AEZS.TO : 2.78 (-1.77%)
AEZS : 2.18 (-0.91%)
Today's Research Reports on Stocks to Watch: EnteroMedics and Aterna Zentaris

NEW YORK, NY / ACCESSWIRE / August 14, 2017 / Aeterna Zentaris was a big winner on Friday despite posting a loss in its second quarter results. Trader confidence may have been a result of one analyst...

AEZS : 2.18 (-0.91%)
ETRM : 2.05 (+3.54%)
Investor Network: Aeterna Zentaris Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 11, 2017 / Aeterna Zentaris Inc. (NASDAQ: AEZS) will be discussing their earnings results in their Q2 Earnings Call to be held on Friday, August 11, 2017 at 8:30 AM Eastern...

AEZS : 2.18 (-0.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

AEterna Zentaris Inc. is a biopharmaceutical company focused on endocrine therapy and oncology. Its lead endocrinology program is a Phase 3 trial in benign prostatic hyperplasia (BPH) with cetrorelix, an LHRH antagonist already marketed for in vitro fertilization under the brand name Cetrotide. The lead...

See More

Key Turning Points

2nd Resistance Point 2.27
1st Resistance Point 2.22
Last Price 2.18
1st Support Level 2.13
2nd Support Level 2.09

See More

52-Week High 4.25
Fibonacci 61.8% 2.92
Fibonacci 50% 2.51
Last Price 2.18
Fibonacci 38.2% 2.11
52-Week Low 0.78

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.